市場調查報告書
商品編碼
1309224
細胞解離市場 - 2018-2028 年全球行業規模、佔有率、趨勢、競爭、機會及預測 按類型、按產品類型、按組織、按最終用戶、按地區細分Cell Dissociation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Product Type, By Tissue, By End User, By Region |
在2024-2028 年的預測期內,全球細胞解離市場預計將以驚人的複合年成長率成長。這主要歸因於生物製藥行業研究的不斷發展、個性化醫療需求的不斷成長以及公共和政府對細胞研究投資的不斷增加等因素。
慢性疾病在人群中的流行率不斷上升,推動了細胞分離技術的市場需求。傳染病的日益流行是全世界人民關注的一個主要健康問題。例如,根據世界衛生組織(WHO)的數據,2019 年有2.96 億人感染慢性乙型肝炎,每年新增感染人數約150 萬。細胞解離在疾病診斷中有著非常重要的應用,因此在預測期內將促進全球細胞解離市場的成長。例如,細胞解離可分離出核酸、RNA 和DNA,並進一步分析鑑定載體,進而鑑定疾病。對無細胞DNA 進行測序可檢測出丙型肝炎、愛滋病、乙型肝炎、鉅細胞病毒和人類T 細胞淋巴細胞病毒等傳染性疾病。
腫瘤組織中的細胞種類繁多,需要多種基於細胞的分析技術來確定不同細胞亞型的特徵。要對腫瘤組織進行進一步研究,需要先用蛋白水解酶將腫瘤組織解離成單細胞,然後使用渦旋或移液技術進行機械分解。微流體設備等技術可用於將消化後的組織集合體解離成單細胞。使用微流體設備可將細胞聚集體快速解離成單細胞,並獲得完全存活的細胞。這種使用微流控裝置的技術也可在無酶條件下使用。因此,這些方法有助於保護疑似腫瘤組織的單細胞檢測和純化方法,從而擴大研究範圍,促進癌症生物學的發展,加強癌症檢測中的分子診斷,從而支持預測期內的市場成長。
生命科學的多個領域對細胞解離的需求日益成長,其研究和治療應用範圍十分廣泛。一些公司開始進行併購,以推動市場成長。例如,2021 年3 月,羅氏診斷公司(Roche Diagnostics)宣布與GenMark 診斷公司(GenMark Diagnostics Inc.通過此次收購,羅氏將獲得GenMark 的ePlex 平台,該平台是一項尖端創新技術,只需一份患者樣本就能檢測多種疾病。這項技術的眾多用途包括快速診斷細菌和病毒性疾病以及抗生素耐藥性。此外,印度、中國、巴西等新興經濟體對生命科學研發的投資增加,也為市場需求提供了支持。例如,印度製藥公司Biocon 在2020 年增加了研發投入,花費了5879 萬美元。
2022 年,市場領先企業賽默飛世爾科技公司在馬斯特里赫特舉行的國際質譜會議上推出了專為高階生物製藥和蛋白質組應用設計的Orbitrap Ascend TriBrid 儀器。
根據給定的市場數據,TechSci Research 可根據公司的具體需求提供客製化服務。報告可提供以下客製化選項:
Global Cell Dissociation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing research in biopharmaceutical industries, growing demand for personalized medicine, and rising public and governmental investments in cell-based research.
Cell dissociation is a significant step in several research applications, such as it is used in developing vaccines and in cell expansion.
Moreover, the rising development in advanced tissue dissociation, increased development & research studies in stem cell research, along with easy differentiation in enzyme-free dissociation products over the enzymatic dissociation products, etc., are factors that are supporting the market growth and are expected to propel it in the forecast period.
The growing prevalence of chronic diseases among the population is propelling the market demand for cell dissociation. The growing prevalence of infectious diseases is a major health concern among people around the world. For instance, according to the World Health Organization (WHO), 296 million people were affected with chronic hepatitis B infection in 2019, with around 1.5 million new infections developing each year. Cell dissociation founds a very significant application in disease diagnosis and thereby adds to the global cell dissociation market growth in the forecast period. For instance, cell dissociation leading to isolation of the nucleic acids, RNA and DNA, is further analyzed for identification of the vector and followed by the identification of the disease. Sequencing of cell-free DNA can result in the detection of infectious diseases such as hepatitis C, HIV, hepatitis B, cytomegalovirus, and human T-cell lymphotropic virus.
Tumor tissues hold a distinct cell range, requiring several cell-based analysis techniques to characterize different cell subtypes. To undergo further research or study of the tumor tissue, it needs to be dissociated into single cells by undergoing treatments with proteolytic enzymes, which is followed by mechanical breakdown using vortexing or pipetting techniques. Techniques such as microfluidic devices are used for the dissociation of digested tissue aggregate into single cells. The microfluidic device usage results in the quick dissociation of cell aggregate into single cells and also results in obtaining cells in fully viable forms. This technique using microfluidic devices can also be used in enzyme-free conditions. These methods thus aid in the protection of single cell detection and purification methods for tumor-suspecting tissue and thereby enhancing the research scope for advancing cancer biology and enhancing molecular diagnosis in cancer detection, thereby supporting the market growth in the forecast period.
There is a growing demand for cell dissociation in multiple fields of life sciences, having a wide range of research and therapeutic applications. Several companies have started mergers and acquisitions to propel the growth of the market. For instance, in March 2021, Roche Diagnostics, announced its partnership with GenMark Diagnostics Inc. Through the acquisition, Roche will have access to GenMark's ePlex platform, a cutting-edge innovation that enables testing for a variety of diseases using just one patient sample. Numerous uses of this technique include the quick diagnosis of bacterial and viral illnesses as well as antibiotic resistance. Additionally emerging economies such as India, China, Brazil, etc. are adding to support the market demand with increased rise in investment in research & development in life sciences. For instance, Indian pharmaceutical company Biocon increased investment and spent USD 58.79 million on research & development in 2020.
In 2022, one of the leading market players, Thermo Fisher Scientific, at the international mass spectroscopy conference in Maastricht, launched the Orbitrap Ascend TriBrid instrument designed for high-end biopharma and proteomic applications.
Global Cell Dissociation Market is segmented based on the type, product type, tissue, end user, region, and competitive landscape. Based on the type, the market is further segmented into tissue dissociation & cell detachment. Based on the product type, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories. Based on tissue, the market is further fragmented into epithelial tissue, connective tissue, and others. Depending on the end user, the market is segmented into Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes, and others. Based on the region, the Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
BD Biosciences, Miltenyi Biotec, Thermo Fisher Scientific, GE Healthcare, Sartorius Group, Lonza, Danaher Corporation, Merck KGaA, STEMCELL Technologies, and QIAGEN., etc.., are some of the major players operating in the Global Cell Dissociation Market.
In this report, Global Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Cell Dissociation Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: